Marked enhancement in myocardial function resulting from overexpression of a human β-adrenergic receptor gene

Carmelo A. Milano; Lee F. Allen; Paul C. Dolber; Thomas D. Johnson; Howard A. Rockman; Richard A. Bond; Robert J. Lefkowitz

doi:10.1016/S0022-5223(95)70384-5

Marked enhancement in myocardial function resulting from overexpression of a human β-adrenergic receptor gene

Carmelo A. Milano, Lee F. Allen, Paul C. Dolber, Thomas D. Johnson, Howard A. Rockman, Richard A. Bond, Robert J. Lefkowitz

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

Abstract

Transgenic mice with intense cardiac expression of human β-adrenergic receptor gene were engineered and shown to display market improvements in baseline myocardial and left ventricular function. Heart/body weight ratios and histologic appearance were not found to be significantly altered, suggesting that receptor gene expression did not induce pathologic changes. Given the substantial reduction in β-adrenergic receptor density and result reduction in inotropic responsiveness observed in chronic heart failure, these finding represent a novel approach for increasing myocardial function with important clinical implications. (J THORAC CARDIOVASC SURG 1995;109:236-41).

Original language	English (US)
Pages (from-to)	236-241
Number of pages	6
Journal	The Journal of thoracic and cardiovascular surgery
Volume	109
Issue number	2
DOIs	https://doi.org/10.1016/S0022-5223(95)70384-5
State	Published - Feb 1995
Externally published	Yes

ASJC Scopus subject areas

Surgery
Pulmonary and Respiratory Medicine
Cardiology and Cardiovascular Medicine

Access to Document

10.1016/S0022-5223(95)70384-5

Cite this

@article{ba0b1b5500c74373b8c0b6286367c5e7,

title = "Marked enhancement in myocardial function resulting from overexpression of a human β-adrenergic receptor gene",

abstract = "Transgenic mice with intense cardiac expression of human β-adrenergic receptor gene were engineered and shown to display market improvements in baseline myocardial and left ventricular function. Heart/body weight ratios and histologic appearance were not found to be significantly altered, suggesting that receptor gene expression did not induce pathologic changes. Given the substantial reduction in β-adrenergic receptor density and result reduction in inotropic responsiveness observed in chronic heart failure, these finding represent a novel approach for increasing myocardial function with important clinical implications. (J THORAC CARDIOVASC SURG 1995;109:236-41).",

author = "Milano, {Carmelo A.} and Allen, {Lee F.} and Dolber, {Paul C.} and Johnson, {Thomas D.} and Rockman, {Howard A.} and Bond, {Richard A.} and Lefkowitz, {Robert J.}",

year = "1995",

month = feb,

doi = "10.1016/S0022-5223(95)70384-5",

language = "English (US)",

volume = "109",

pages = "236--241",

journal = "The Journal of thoracic and cardiovascular surgery",

issn = "0022-5223",

publisher = "Elsevier Inc.",

number = "2",

}

TY - JOUR

T1 - Marked enhancement in myocardial function resulting from overexpression of a human β-adrenergic receptor gene

AU - Milano, Carmelo A.

AU - Allen, Lee F.

AU - Dolber, Paul C.

AU - Johnson, Thomas D.

AU - Rockman, Howard A.

AU - Bond, Richard A.

AU - Lefkowitz, Robert J.

PY - 1995/2

Y1 - 1995/2

N2 - Transgenic mice with intense cardiac expression of human β-adrenergic receptor gene were engineered and shown to display market improvements in baseline myocardial and left ventricular function. Heart/body weight ratios and histologic appearance were not found to be significantly altered, suggesting that receptor gene expression did not induce pathologic changes. Given the substantial reduction in β-adrenergic receptor density and result reduction in inotropic responsiveness observed in chronic heart failure, these finding represent a novel approach for increasing myocardial function with important clinical implications. (J THORAC CARDIOVASC SURG 1995;109:236-41).

AB - Transgenic mice with intense cardiac expression of human β-adrenergic receptor gene were engineered and shown to display market improvements in baseline myocardial and left ventricular function. Heart/body weight ratios and histologic appearance were not found to be significantly altered, suggesting that receptor gene expression did not induce pathologic changes. Given the substantial reduction in β-adrenergic receptor density and result reduction in inotropic responsiveness observed in chronic heart failure, these finding represent a novel approach for increasing myocardial function with important clinical implications. (J THORAC CARDIOVASC SURG 1995;109:236-41).

UR - http://www.scopus.com/inward/record.url?scp=0028799640&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028799640&partnerID=8YFLogxK

U2 - 10.1016/S0022-5223(95)70384-5

DO - 10.1016/S0022-5223(95)70384-5

M3 - Article

C2 - 7853876

AN - SCOPUS:0028799640

SN - 0022-5223

VL - 109

SP - 236

EP - 241

JO - The Journal of thoracic and cardiovascular surgery

JF - The Journal of thoracic and cardiovascular surgery

IS - 2

ER -

Marked enhancement in myocardial function resulting from overexpression of a human β-adrenergic receptor gene

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this